A股異動 | 環球印務(002799.SZ)漲逾5% 與武漢生物簽訂疫苗產品包裝採購訂單
格隆匯11月13日丨環球印務(002799.SZ)漲停價開盤後持續回落,現報18.77元,漲幅5.57%,最新總市值33.8億。公司表示,輝瑞公司所產新冠疫苗是由美國輝瑞和德國生物科技公司BioNTech聯合研製,暫未在國內生產。目前,公司與武漢生物簽訂了未來一年涉及新冠疫苗產品包裝及其他疫苗產品包裝的採購訂單,為此我們已合理佈局產能,努力服務好現有疫苗企業客户,並積極拓展新客户。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.